Diagnostic Differences Between Allergic Bronchopulmonary Aspergillosis and Chronic Eosinophilic Pneumonia

Authors

  • Khamraeva N. A. Senior Lecturer at the Department of Clinical Disciplines, PhD Faculty of Medicine, NSEI “Alphraganus” University, Tashkent, Uzbekistan

Keywords:

Allergic bronchopulmonary aspergillosis (ABPA), Chronic eosinophilic pneumonia (CEP), Pulmonary eosinophilia, Diagnosis, Misdiagnosis, Uzbekistan, Resource-limited settings, High-resolution computed tomography (HRCT), Aspergillus fumigatus, Aspergillus-specific IgE, Beta-D glucan, Immunologic markers, Clinical features, Radiologic findings, Treatment

Abstract

In Uzbekistan, the differentiation between allergic bronchopulmonary aspergillosis (ABPA) and chronic eosinophilic pneumonia (CEP) is challenging due to limited data and similar clinical presentations. Both conditions show peripheral eosinophilia, leading to frequent misdiagnosis. This study aimed to investigate the clinical and radiographic differences between ABPA and CEP-like presentations to improve diagnosis in Uzbekistan. A retrospective analysis of 25 patients with ABPA from 2015 to 2019 was conducted. Patients were grouped based on high-resolution computed tomography (HRCT) findings: those with CEP-like features and those with typical ABPA. Clinical and immunologic data were compared. Results showed that while both groups had similar eosinophil counts and Aspergillus-specific immunoglobulin E (IgE) levels, only the non-CEP group showed a significant correlation between eosinophils and IgE. The non-CEP group also had higher levels of the fungal marker beta-D glucan. Recurrence rates were high, but no progression from CEP-like to typical ABPA was observed. These findings emphasize the importance of Aspergillus-specific IgE testing for accurate diagnosis and management of pulmonary eosinophilia in Uzbekistan, potentially preventing misdiagnosis and improving patient outcomes.

References

Agarwal, R., Chakrabarti, A., Shah, A., et al. (2013). Allergic bronchopulmonary aspergillosis: Review of literature and proposal of new diagnostic and classification criteria. Clinical and Experimental Allergy, 43(8), 850–873. - A comprehensive review of ABPA, covering diagnosis, classification, and proposed new criteria.

Cottin, V. (2016). Eosinophilic lung diseases. Clinics in Chest Medicine, 37(3), 535–556. - An overview of eosinophilic lung diseases, including ABPA and CEP, discussing their clinical presentations, diagnosis, and management.

Greenberger, P. A., & Patterson, R. (1987). The diagnosis and management of allergic bronchopulmonary aspergillosis. Annals of Allergy, 58(2), 134–139. - A classic paper on the diagnosis and treatment of ABPA.

Hinson, K. F. W., Moon, A. J., & Plummer, N. S. (1952). Broncho-pulmonary aspergillosis: A review and a report of eight new cases. Thorax, 7(4), 317–333. - The seminal paper describing ABPA, outlining its initial clinical features.

Suzuki, Y., & Suda, T. (2019). Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management. Allergology International, 68(4), 413–419. - A recent review focusing on eosinophilic pneumonia, including CEP and its clinical manifestations.

Agarwal, R., Maskey, D., Aggarwal, A. N., et al. (2013). Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: A latent class analysis. PLOS ONE, 8(4), e61105. - Examines the diagnostic accuracy of various tests for ABPA.

Agarwal, R., Khan, A., Gupta, D., et al. (2010). An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLOS ONE, 5(12), e15346. - Proposes a new classification system for ABPA based on HRCT findings of high-attenuation mucus.

Phuyal, S., Garg, M. K., Agarwal, R., et al. (2016).High-attenuation mucus impaction in patients with allergic bronchopulmonary aspergillosis: Objective criteria on high-resolution computed tomography and correlation with serologic parameters. Current Problems in Diagnostic Radiology, 45(3), 168–173. - Highlights the role of high-attenuation mucus on HRCT in diagnosing ABPA.

Denning, D. W., et al. (2015). Evolving concepts in the diagnosis and management of allergic bronchopulmonary aspergillosis: An international consensus statement. Mycoses, 58(1), 1–19. - Provides an international consensus statement on the diagnosis and management of ABPA.

Singh, M., Agarwal, R., & Singh, S. (2017). Diagnostic dilemma in allergic bronchopulmonary aspergillosis: A review. Lung India, 34(1), 1–7. - Addresses the diagnostic challenges in ABPA, emphasizing the need for accurate differentiation from other eosinophilic lung diseases.

Babu, G., & Singh, S. (2016). Allergic bronchopulmonary aspergillosis: Diagnostic challenges in resource-limited settings. Journal of Asthma, 53(3), 264–268. - Discusses the specific challenges of diagnosing ABPA in resource-limited settings.

De, P., Chatterjee, S., & Chakrabarti, A. (2015). Allergic bronchopulmonary aspergillosis: An emerging global threat in resource-limited settings. Indian Journal of Chest Diseases & Allied Sciences, 57(4), 311–315. - Outlines the global impact of ABPA, especially in resource-limited settings.

Sharma, S., & Agarwal, R. (2013). Allergic bronchopulmonary aspergillosis: Diagnostic dilemma in resource-limited settings. Lung India, 30(1), 1–7. - Addresses the challenges of diagnosing ABPA in resource-limited settings in India.

Chakrabarti, A., Agarwal, R., & Singh, S. (2011). Allergic bronchopulmonary aspergillosis: A review of its pathogenesis, diagnosis, and management. Journal of Asthma, 48(8), 719–728. - Provides a comprehensive overview of ABPA, covering its pathogenesis, diagnosis, and treatment.

Chung, K. F., & Leung, D. Y. M. (2004). Chronic eosinophilic pneumonia. The Lancet, 363(9413), 1001–1009. - Focuses on the pathogenesis, diagnosis, and management of CEP.

Greenberger, P. A. (2007). Allergic bronchopulmonary aspergillosis: Diagnosis, treatment, and follow-up. Journal of Allergy and Clinical Immunology, 120(5), 1139–1144. - Provides guidelines for the diagnosis and treatment of ABPA.

Kuhn, L. A., & Greenberger, P. A. (2002). Chronic eosinophilic pneumonia. American Journal of Respiratory and Critical Care Medicine, 165(4), 575–588. - A detailed review on the epidemiology, clinical features, and management of CEP.

Patterson, R., & Greenberger, P. A. (1993). Allergic bronchopulmonary aspergillosis: An update. Journal of Allergy and Clinical Immunology, 91(6 Pt 1), 1139–1147. - Provides an update on the understanding and management of ABPA.

Downloads

Published

2025-01-31

How to Cite

N. A., K. (2025). Diagnostic Differences Between Allergic Bronchopulmonary Aspergillosis and Chronic Eosinophilic Pneumonia. International Journal of Integrative and Modern Medicine, 3(1), 256–262. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/1506